Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determination of HIV tropism and its use in the clinical practice.

Expert review of anti-infective therapy - 1 Dec 2013

Pérez-Olmeda Mayte, Alcami José

Abstract excerpt

Assessment of HIV coreceptor tropism assay is recommended before starting therapy with CCR5 coreceptor antagonists. So far, only maraviroc (MVC) has been approved for clinical use and a tropism assay is mandatory for patients with virological failure or patients in which MVC is considered into future treatment options. Viral tropism can be assessed with either genotypic or phenotypic methods and to this aim...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Assay
Share to Cyclohexanes
Share to HIV Fusion Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Typing

Share to Receptors, CCR5

Share to Receptors, CXCR4

Share to Triazoles

Share to Viral Tropism

Source

Identifiers

PMID: 24191978
DOI: 10.1586/14787210.2013.852469

Genes

CCR5
CXCR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determination of HIV tropism and its use in the clinical practice.PMID 24191978Read ↗

Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists.Semantic proximity Read ↗

Phenotyping methods for determining HIV tropism and applications in clinical settings.Semantic proximity Read ↗

Phenotypic assays for the determination of coreceptor tropism in HIV-1 infected individuals.Semantic proximity Read ↗

[Methods for determination of HIV tropism and their clinical use].Semantic proximity Read ↗

Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment.Semantic proximity Read ↗

Reliable genotypic tropism tests for the major HIV-1 subtypes.Semantic proximity Read ↗

Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists.Semantic proximity Read ↗

Current tests to evaluate HIV-1 coreceptor tropismSemantic proximity Read ↗

Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use.Semantic proximity Read ↗

The utility of genotypic tropism testing in clinical practice.Semantic proximity Read ↗

Determination of HIV-1 coreceptor tropism in clinical practise.Semantic proximity Read ↗

Tropism testing in the clinical management of HIV-1 infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.